|
|
Office Locations:
|
875 North Michigan Ave., Suite 3214
Chicago, IL 60611
Phone: 312-683-1900
Fax: 312-683-1881
| |
|
|
|
|
Business Services
Consumer Products & Services
Energy & Clean Tech
Life Sciences & Healthcare
Manufacturing & Industrial
Transportation & Distribution
|
|
|
Established in 1995, Valor Equity Partners is a lower middle market private equity firm. Valor invests in companies that have sustainable revenues derived from a strategic or niche market position, but present complex, difficult due diligence issues and face constraints to revenue growth, profitability improvements, and enhanced returns on capital that limit the development into larger market growth companies. Such constraints typically involve inadequate strategic planning, expansion capital, marketing infrastructure, process improvement techniques, information systems and/or human resource infrastructure. Valor seeks control investments in businesses with an EBITDA of $5-$15 million. The firm has no minimum size for Add-on investments. Typical equity investments range from $10-$30 million per transaction. Valor's industry preferences include: Industrial Products & Manufacturing, Infrastructure & Industrial Maintenance, Value-added Distribution, Energy Services, Healthcare, Business Services, and Consumer.
|
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
COMPANY STAGE | REVENUE |
Venture Capital | |
Seed Stage (includes "pre-seed," or concept stage) | No Revenue |
Early Stage | Minimal Revenue |
Growth Stage (also called Mid-stage) | $2M-$7M |
Expansion Stage (also called Late-stage) | $7M and greater |
Private Equity | |
Lower Middle Market | $10M-$249M |
Middle Market | $250M-$499M |
Upper Middle Market | $500M-$1B |
Large Cap | >$1B |
|
|
|
|
|
Name | |
| |
Title | |
|
Anne Marie Morley | |
| |
Chief Financial Officer | |
Antonio J. Gracias | |
| |
Founder, Chief Executive Officer and Chief Investment Officer | |
Bradley Sheftel | |
| |
Managing Director | |
Bruce Johns | |
| |
Senior Director | |
Christopher Murphy | |
| |
Managing Director | |
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
03/10/2025
|
Nirvana Insurance
|
CA
|
$80,000,000
|
Series C
|
03/04/2025
|
Aescape
|
NY
|
$83,000,000
|
Strategic
|
02/27/2025
|
Loyal
|
CA
|
$22,000,000
|
Series B-2
|
02/27/2025
|
CompScience
|
CA
|
$27,600,000
|
Series B
|
09/12/2024
|
Strider Technologies
|
UT
|
$55,000,000
|
Series C
|
07/01/2024
|
K Health
|
NY
|
$50,000,000
|
|
05/15/2024
|
Weka.IO
|
CA
|
$140,000,000
|
Series E
|
03/21/2024
|
Loyal
|
CA
|
$45,000,000
|
Series B
|
03/15/2024
|
Extropic
|
CA
|
$14,100,000
|
Seed
|
|
|
|
|
|